To Affinity and Beyond: A Personal Reflection on the Design and Discovery of Drugs
Faced with new and as yet unmet medical need, the stark underperformance of the pharmaceutical discovery process is well described if not perfectly understood. Driven primarily by profit rather than societal need, the search for new pharmaceutical products—small molecule drugs, biologicals, and vacc...
Main Author: | Darren R. Flower |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/21/7624 |
Similar Items
-
Case studies in modern drug discovery and development /
by: Huang, Xianhai, et al.
Published: (c201) -
Atropisomeric fragments in drug discovery and probe compound development
by: Danet, B
Published: (2022) -
Abscondita competentia
by: Carlo Olmo
Published: (2022-12-01) -
Natural product guided antibacterial drug discovery: tetramates as core scaffolds
by: Panduwawala, T
Published: (2016) -
Machine Learning for Drug Discovery /
by: Melo, Marcelo C.R., author 652450, et al.
Published: (2022)